Ratio Therapeutics, Inc.

CIK 2004792 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ratio Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 31, 2026D0002004792-26-000001
Dec 21, 2023D0002004792-23-000001